- Home
- CGON vs TFIN Comparison
CGON vs TFIN Comparison
Compare CGON & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- TFIN
- Stock Information
- Founded
- CGON 2010
- TFIN 1981
- Country
- CGON United States
- TFIN United States
- Employees
- CGON N/A
- TFIN N/A
- Industry
- CGON
- TFIN Major Banks
- Sector
- CGON
- TFIN Finance
- Exchange
- CGON NYSE
- TFIN Nasdaq
- Market Cap
- CGON 2.3B
- TFIN 2.1B
- IPO Year
- CGON 2024
- TFIN N/A
- Fundamental
- Price
- CGON $29.08
- TFIN $90.75
- Analyst Decision
- CGON Strong Buy
- TFIN Hold
- Analyst Count
- CGON 10
- TFIN 5
- Target Price
- CGON $65.11
- TFIN $71.80
- AVG Volume (30 Days)
- CGON 809.2K
- TFIN 124.6K
- Earning Date
- CGON 02-02-2025
- TFIN 01-22-2025
- Dividend Yield
- CGON N/A
- TFIN N/A
- EPS Growth
- CGON N/A
- TFIN N/A
- EPS
- CGON N/A
- TFIN 0.80
- Revenue
- CGON $684,000.00
- TFIN $398,012,000.00
- Revenue This Year
- CGON $210.00
- TFIN N/A
- Revenue Next Year
- CGON N/A
- TFIN $10.13
- P/E Ratio
- CGON N/A
- TFIN $113.60
- Revenue Growth
- CGON 258.12
- TFIN N/A
- 52 Week Low
- CGON $25.77
- TFIN $66.85
- 52 Week High
- CGON $50.23
- TFIN $110.58
- Technical
- Relative Strength Index (RSI)
- CGON 44.86
- TFIN 47.80
- Support Level
- CGON $27.70
- TFIN $82.46
- Resistance Level
- CGON $29.69
- TFIN $92.44
- Average True Range (ATR)
- CGON 1.43
- TFIN 2.63
- MACD
- CGON 0.16
- TFIN 0.49
- Stochastic Oscillator
- CGON 31.29
- TFIN 83.11
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Corporate. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The corporate segment includes holding company financing and investment activities and management and administrative expenses to support the overall operations of the Company.